BlackRock Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BlackRock Group’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,418	Closed	-$130K	–	3062
2016 Q1	$130K	Buy	1,418 +1,021	+257%	+$102K	﹤0.01%	2685
2015 Q4	$80K	Sell	397 -298	-43%	-$59.5K	﹤0.01%	2743
2015 Q3	$104K	Buy	695 +343	+97%	+$252K	﹤0.01%	2700
2015 Q2	$334K	Buy	352 +31	+10%	+$25.3K	﹤0.01%	2414
2015 Q1	$235K	Buy	321 +220	+218%	+$165K	﹤0.01%	2447
2014 Q4	$80K	Buy	+101	New	+$54.4K	﹤0.01%	2699
2014 Q3	–	Sell	-1,534	Closed	-$414K	–	2900
2014 Q2	$414K	Buy	+1,534	New	+$329K	﹤0.01%	2276
2013 Q4	–	Sell	-885	Closed	-$201K	–	2823
2013 Q3	$201K	Buy	+885	New	+$155K	﹤0.01%	2480

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock Group's TTPH Position: Q2 2016 in Review

BlackRock Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 1,418 shares — an estimated $130K sold.

BlackRock Group first reported a position in TTPH in Q3 2013 and held it in 8 quarters. The position peaked at $414K in Q2 2014. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

BlackRock Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
BlackRock Group sold 1,418 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $130K.
BlackRock Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 8 quarters.
BlackRock Group's Tetraphase Pharmaceuticals, Inc. position peaked at $414K in Q2 2014.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.